ヘルスとヘルスケア
Cómo la IA está reviviendo una solución centenaria contra la resistencia a los antibióticos
El espectro de una era postantibiótica, en la que las infecciones comunes podrían volver a ser mortales, está emergiendo lentamente.
Ithri Benamara is CEO Associate at phagos, a biotech startup developing AI-powered phage therapy. He previously worked as a VC at EQT Ventures, one of Europe's leading investment firms, where he focused on identifying and backing transformative technology companies. Prior to EQT, Ithri also contributed to scaling carbon removal technologies with ClimeFi. He holds Master's degrees in Climate Change & Sustainable Finance from Ecole des Mines de Paris and EDHEC Business School.
